Cerebral vasculitis during FK 506 treatment in a liver transplant patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9566415.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The immunosuppressive agent FK 506 is widely used in liver transplant patients. Neurotoxicity is a major complication of its use. We report progressive and irreversible neurologic complications occurring in a 39-year-old woman who underwent liver transplantation and was treated with FK 506. Neuropathologic examination revealed multiple vasculitic lesions. The possibility of an FK 506-mediated toxic effect on the cerebral vessels is suggested.
Medical subject headings
- Cerebral Arteries
- Immunosuppressive Agents
- Liver Transplantation
- Tacrolimus
- Vasculitis